0
Editor's Correspondence |

Oral Antibiotics and Outcome in Meningococcemia—Reply

Nicolau Barquet, MD; Pere Domingo, MD; Joan A. Caylà, MD
Arch Intern Med. 2000;160(14):2221. doi:.
Text Size: A A A
Published online

Extract

In reply

We are grateful for the favorable comments and suggestions of Nonell and colleagues, and we consider their question about whether there are differences between the capacity of preadmission antibiotic therapy administered parenterally or orally to prevent the mortality and sequelae of meningococcal disease to be extremely interesting. Of the 281 patients in our study who underwent preadmission antibiotic therapy, 40 (14.2%) received it parenterally while 241 (85.8%) received it orally. No patient of those who received parenteral preadmission antibiotic therapy presented sequelae or died. Statistically significant differences were found between the administration of preadmission antibiotics, either parenterally or orally, and the lack of preadmission antibiotic therapy, in relation to mortality and sequelae (Table 1). No statistically significant differences were found between parenteral and oral preadmission antibiotic therapy in their capacity to prevent death or sequelae in patients with meningococcal disease. However, the small number of cases with prior parenteral antibiotic therapy could explain this absence of statistical significance.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario

brightcove.createExperiences();